SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Total Current Assets | ₹275 Cr | ₹182 Cr | ₹140 Cr | ₹87 Cr | ₹92 Cr |
What is the latest Total Current Assets ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Total Current Assets |
---|---|
Mar2024 | ₹275 Cr |
Mar2023 | ₹182 Cr |
Mar2022 | ₹140 Cr |
Mar2017 | ₹87 Cr |
Mar2016 | ₹92 Cr |
How is Total Current Assets of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Total Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹275 Cr | 51.24 | |
Mar2023 | ₹182 Cr | 29.96 | |
Mar2022 | ₹140 Cr | 61.55 | |
Mar2017 | ₹87 Cr | -5.59 | |
Mar2016 | ₹92 Cr | - |
Compare Total Current Assets of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹2,053.9 Cr | 5.3% | 29.8% | 84.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,768.0 Cr | 0.4% | -1.2% | 12.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,468.0 Cr | 2.6% | 8.4% | 48.5% | Stock Analytics | |
CIPLA | ₹121,326.0 Cr | -0.1% | 0.5% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,757.0 Cr | 3.2% | 11.8% | 11.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,345.0 Cr | 3.4% | 0.5% | 12.8% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | 5.3% |
29.8% |
84.3% |
SENSEX | 0.3% |
0.7% |
8.8% |
You may also like the below Video Courses